The size of the Defibrillators Market in the Middle East & Africa was around USD 0.77 Billion in 2022 and is expected to grow at a CAGR of 5.4% to reach USD 1.00 billion by 2027.
Increasing adoption of technologically advanced defibrillators and an increase in the incidence of CVDs, and an aging population with an increased risk of targeted illnesses are some of the major factors driving demand for defibrillators in the MEA.
CRT-Ds that are MRI compatible are expected to give growing opportunities for developing and emerging economies. Moreover, the public and commercial organizations are focusing on developing new technologies in the medical industry. The number of training institutes is increasing, all of which are encouraging market growth.
Increasing investment and funding by the government to improve the quality of diagnostic and treatment processes and rising urbanization and disposable income are likely to boost the Middle East defibrillators market growth during the forecast period. In addition, during the Covid-19 pandemic, the international liaison committee on cardiopulmonary resuscitation modified the resuscitation guidelines, ensuring enhanced defibrillation delivery through increased healthcare worker training and decreasing uncertainty in pandemic resuscitation efforts.
Furthermore, the increased concern for quality treatment methods and improving patient health and changes in food choices, and the adoption of sedentary lifestyles indirectly contribute to the defibrillator market in the Middle East and Africa.
A shortage of qualified personnel who can run and analyze systems more efficiently slows the market's growth rate. Lack of consistency, failure of real-time operations, and technicians' lack of expertise in handling issues are all constraints to market growth. Furthermore, these systems necessitate significant deployment and maintenance, which is a substantial burden to healthcare professionals.
This research report on the Middle East and Africa defibrillators market has been segmented and sub-segmented into the following categories:
By End User:
Regionally, the MEA region is capturing around 3% of the global defibrillators market. The market growth is majorly driven by the supportive legislative reforms, increased occurrences of sudden cardiac arrests in the region, integrated technologies, and rising awareness for cardiac disorders. Furthermore, the pandemic heightened the need for defibrillators since many older people suffering from viral infection experienced abrupt cardiac arrests, making the device useful for resuscitation. Due to supportive healthcare infrastructure and broader adoption of technologically advanced devices, the Middle East and Africa held the most significant revenue share in 2020. On the other hand, due to the existence of expanding economies such as the United Arab Emirates and Kuwait and rising healthcare expenditure, the market in the Middle East and Africa is expected to grow.
South Africa held the largest share of the MEA defibrillators market and is projected to witness the largest share of the market during the forecast period owing to the improving healthcare infrastructure, technological advancements, and growing healthcare expenditure. In addition, increased public awareness of the availability of various treatment techniques, growing government assistance to improve the quality of diagnostic and treatment processes, and increasing urbanization and disposable income are likely to boost the defibrillator market.
On the other hand, emerging countries such as UAE and Saudi Arabia are projected to record a promising share and contribute to the MEA regional market growth. The increasing need for both implanted and external defibrillators, increasing healthcare spending, healthcare infrastructure, and innovative products are fuelling the market growth.
KEY MARKET PLAYERS:
Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), and Nihon Kohden Corporation (Japan) are some of the notable companies operating in the MEA defibrillators market.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Implantable Cardioverter Defibrillators (ICDS)
188.8.131.52 Transvenous Implantable Cardioverter Defibrillators (T-ICDS)
184.108.40.206.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
220.127.116.11.2 Dual-Chamber ICDS
18.104.22.168.3 Single-Chamber ICDS
22.214.171.124 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
5.1.3 External Defibrillators
126.96.36.199 Automated External Defibrillators (AEDS)
188.8.131.52.1 Semi-Automated External Defibrillators
184.108.40.206.2 Fully Automated External Defibrillators
220.127.116.11 Manual External Defibrillators
18.104.22.168 Wearable Cardioverter Defibrillators (WCDS)
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 End User
5.2.2 Hospitals, Clinics, & Cardiac Centers
5.2.4 Public Access Markets
5.2.5 Home Care
5.2.6 Alternate Care Markets
5.2.7 Y-o-Y Growth Analysis, By End User
5.2.8 Market Attractiveness Analysis, By End User
5.2.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Product
188.8.131.52 By End User
6.1.4 Market Attractiveness Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By End User
6.1.5 Market Share Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Product
188.8.131.52 By End User
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic PLC
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 St. Jude Medical, Inc.
8.3 Boston Scientific Corporation
8.4 Philips Healthcare (A Division of Koninklijke Philips N.V.)
8.5 Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
8.6 Biotronik Se & Co.Kg
8.7 Physio-Control International, Inc.
8.8 Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
8.9 Sorin Group (Now Livanova PLC)
8.10 Nihon Kohden Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.